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ABSTRACT
The catalytic steps through which DNA topoisome-
rases produce their biological effects and the inter-
ference of drug molecules with the enzyme–DNA
cleavage complex have been thoroughly investi-
gated both from the biophysical and the biochemi-
cal point of view. This provides the basic structural
insight on how this family of essential enzymes
works in living systems and how their functions
can be impaired by natural and synthetic com-
pounds. Besides other factors, the physiological
environment is known to affect substantially the bio-
logical properties of topoisomerases, a key role
being played by metal ion cofactors, especially diva-
lent ions (Mg
2+), that are crucial to bestow and
modulate catalytic activity by exploiting distinctive
chemical features such as ionic size, hardness and
characteristics of the coordination sphere including
coordination number and geometry. Indeed, metal
ions mediate fundamental aspects of the topo-
isomerase-driven transphosphorylation process by
affecting the kinetics of the forward and the reverse
steps and by modifying the enzyme conformation
and flexibility. Of particular interest in type IA
and type II enzymes are ionic interactions involving
the Toprim fold, a protein domain conserved
through evolution that contains a number of acidic
residues essential for catalysis. A general two-metal
ion mechanism is widely accepted to account for
the biophysical and biochemical data thus far
available.
Metal ions are important modulators of the biological
response (1). Indeed, in nearly one-third of enzyme-
mediated processes, metal ion cofactors are required
for activity. Metals are involved in redox (30%) and
non-redox catalysis (70%). In the latter case, the most
signiﬁcant property is Lewis acidity, related to the power
of a reaction centre to attract electrons. In fact, the metal
removes electron density from the ligand and causes polar-
ization of the substrate/cofactor reactive bonds, thereby
increasing its electrophilic character.
MAGNESIUM AS THE MAJOR METAL COFACTOR
IN NUCLEIC ACID-DIRECTED ENZYMES
In cell systems, magnesium represents an abundant species
as it is present in the millimolar range (2). In line with this,
it is largely utilized for electrostatic stabilization and
electrophilic activation of substrates by polarization of
X–O (X=P,C) bonds. A special case is represented by
water, which can be bound rather eﬃciently in the inner
sphere coordination and is available for catalytic complex
hydration as well as for hydrolytic processes. Magnesium
is by far the most frequently found metal ion cofactor in
enzymatic systems. This is most likely related to Mg
2+
ability to form stable complexes with phosphate-contain-
ing species, including ATP, which is normally associated
with the metal ion when acting in a physiological environ-
ment (1,3).
Moreover, essential biomacromolecules such as DNA
and RNA eﬃciently bind to Mg
2+ as it participates in
neutralization of the polyanionic charge of the nucleic
acid. In fact, this metal ion is characterized by a small
atomic radius (0.72A ˚ ) and an elevated hardness, which
makes it especially suitable for coordination to oxygen
atoms, which are hard ligands (3–6).
As a corollary of reduced ionic dimensions, large
coordinating groups are inadequately accommodated by
Mg
2+ enzymes. Outer-sphere mechanisms, in which the
substrate is connected to the enzymatic machinery through
solvent bridge(s), are often operating to deal with coordi-
nation problems. In this connection, a hydrogen bonding
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presentation of the reacting species.
ONE- VERSUS TWO ION MECHANISMS IN
MAGNESIUM-DEPENDENT ENZYMATIC
DNA MANIPULATION
An interesting issue arising from biochemical and biophy-
sical studies has to do with the number of metal ions
participating in hydrolytic processes involving the phos-
phodiester bond in nucleic acids (5,7).
There is not a unique metal ion:enzyme stoichiometry
reported for DNA-processing enzymes such as nucleases
(8). Indeed one, two or three metal ion-mediated mecha-
nisms are currently proposed. Among these, a widely
accepted mechanistic model envisages the concerted
action of two Mg
2+ ions located closely to each other
and eventually sharing common coordination sites in the
protein (9). Notable examples are T4 RNase H, T5
50-exonuclease, Endonuclease V as well as other restriction
endonucleases (10–14).
Two-metal ion mechanisms in non-redox processes
bear a number of advantages over processes involving a
single ion (15–17):
  Activation barriers arising from nuclear reorganization
of the solvent and the enzyme can be reduced in binu-
clear versus mononuclear centres having the same net
charge, due to greater charge delocalization.
  Polyatomic substrates can generally be accommodated
better at binuclear centres.
  Electrostatic activation of substrate or ionization of a
proton from an active-site water molecule will occur
more readily at a charged binuclear centre, than at the
corresponding mononuclear one. The binuclear elec-
trostatic eﬀect is estimated at least 3 pK units to the
free energy of dissociation of a proton from a water
ligand compared to the corresponding mononuclear
aquo species.
  Formation of a low-energy transition state, for exam-
ple the negatively charged trigonal-bipyramidal tran-
sition state formed during phosphodiester bond
hydrolysis ( 2 net charge) by nucleases and RNase
H, is predicted to be energetically favoured by sym-
metrical coordination of the axial ligands to the metal
ions of a binuclear centre. This geometry is achieved in
exonucleases via formation of two bidentate bridges
involving an equatorial phosphate O atom.
The second metal ion in binuclear complexes can attenu-
ate the strength of the bridging-ligand ﬁeld potential as
shown by EPR studies on Mn
2+, an ion which can often
replace magnesium in nucleic acid processing enzymes. A
weakened bridging-ligand ﬁeld potential may enhance the
binding aﬃnity to other ligands, above all water, thereby
increasing the Lewis acidity (17).
The preference for Mg
2+ should result from the chem-
ical environment and the need for placing two metal ions
at a distance of  4A ˚ . The stringent requirement for two
Mg
2+ coordination is likely to be the basis for catalytic
speciﬁcity by the two-metal ion mechanism. In fact, unlike
other divalent ions, two Mg
2+ ions can be optimally coor-
dinated at the appropriate distance (between 3A ˚ and 4A ˚ )
to facilitate phosphoryl transfer. In contrast, catalytic spe-
ciﬁcity of one-metal ion-dependent nucleases, for which
metal requirement and substrate speciﬁcity are less
severe, seems to derive from substrate binding.
Nevertheless, a link between one- and two-metal ion catal-
ysis has been very recently proposed (18). In fact, struc-
tural and functional analysis of nucleotidyl transfer
enzymes shows that the two apparently unrelated types
of mechanism share a catalitically equivalent metal ion,
the second metal ion being eventually replaced by a
basic amino acid in the one-metal ion systems.
An additional interesting aspect of Mg-mediated bio-
chemical reactions involving nucleic acid cleavage is the
possibility of a ‘moving metal mechanism’ in which one
of the Mg
2+ ions moves from a more buried to a more
exposed site as a result of the structural and electronic
changes that occur during substrate cleavage. In fact,
based on the diﬀerent positions of the metal ions at the
EcoRV active site a catalytic mechanism using two metal
ions in three diﬀerent positions has been proposed (19,20).
Further studies on the mechanism of T5 ﬂap endonu-
clease are also consistent with a two-metal ion process for
chemical catalysis. However, the overall biochemical pro-
cess carried out by this enzyme is more complex and
apparently requires three ions to be completely rational-
ized (21).
MAGNESIUM IONS IN TOPOISOMERASE-
MEDIATED DNA PROCESSING
Among DNA-backbone processing enzymes, topoisome-
rases play a central role. They participate in essential cel-
lular processes, such as DNA replication, transcription
and chromosome condensation, which require enzymes
able to regulate the ensuing topological changes produced
in the nucleic acid. Their biological, biophysical and struc-
tural properties have been carefully reviewed and their
molecular mechanism(s) of action thoroughly described
(22,23). Brieﬂy, topoisomerases produce a topological
change in a DNA chain by the unwinding or the super-
coiling of the double helix thereby releasing the torsional
strain imposed by DNA processing. This can occur only
by transient formation of a break along the DNA phos-
phodiester backbone, followed by strand passage through
the gate and ﬁnally by the resealing of the backbone
break. The topoisomerase-mediated cleavage process con-
sists of a nucleophilic attack of a tyrosine residue located
in the catalytic pocket to a phosphodiester bond of the
nucleic acid backbone. The transphosphorylation reaction
produces a covalent protein–nucleic acid linkage and a
free hydroxyl moiety at the split deoxyribose group. The
topological change is generated by controlled rotation of
the cleaved strand around the intact ﬁlament or by strand
passing of a DNA ﬁlament through the gate produced by
cleavage. This is followed by the resealing of the original
bond through phosphoryl transfer from the tyrosine
residue to the split deoxyribose hydroxyl. Release of the
covalent enzyme–DNA linkage concludes the catalytic
Nucleic AcidsResearch, 2009, Vol.37,No. 3 703cycle (24,25). Depending upon the number of DNA
strands involved in the cleavage reaction topoisomerases
can be divided into type I (single-strand break) and type II
(double-strand break). Each cellular organism contains at
least one type I and one type II topoisomerase component.
Further categorizations take into account the proteins’
amino-acidic sequence and structure, the reaction mecha-
nism and the sugar position (50 or 30) at which the protein
becomes covalently linked to the nucleic acid through the
phosphate group. Relevant topoisomerase properties are
summarized in Table 1.
Interestingly, topoisomerase IA and topoisomerase II
bind covalently to the 50-phosphoryl group of the cleaved
DNA, whereas topoisomerases IB and IC are linked to the
30-phosphoryl group.
Topoisomerases often require cofactors for full catalytic
activity. ATP (type II family and reverse gyrase) regulates
the conformational changes required for enzyme action
through binding and hydrolysis processes. Divalent
metal ions, essentially Mg
2+, are also important as they
perform both structural and catalytic functions, besides
acting in complex with ATP. In fact, topoisomerase IA
and topoisomerases II require Mg
2+ to relax supercoiled
DNA (22,26). In the case of the type IB enzymes a metal
ion is not required to participate in the catalytic cycle and
does not directly bind the protein. However, Mg
2+ eﬀec-
tively stimulates catalytic activity, probably facilitating the
rate-limiting DNA-release step at the end of the enzymatic
cycle (27,28).
Mg
2+ can assist the transphosphorylation process in
several ways, as summarized in Figure 1. In fact, it can
operate according to a general base (outer sphere)
mechanism, stabilize the incoming negative tyrosinate
species, neutralize the pentacoordinate negatively charged
transition state and/or assist in the stabilization of the
negatively charged leaving group (3). Even if a number
of investigations have been performed to simulate nucleic
acid hydrolytic processes, no accurate quantum mechan-
ical studies on this metal ion-mediated process are
available as yet. In particular, it would be of interest to
fully understand the factors that induce preferential attack
of outer sphere tyrosine versus inner sphere water in
topoisomerases, the reverse occurring in the related class
of nucleases. Indeed, conserved tyrosine residues are
often located in the active site of DNA nucleases and
polymerases (Klenow fragment, T5 ﬂap endonuclease,
staphylococcal nuclease), yet they do not appear to par-
ticipate in catalysis but aid stabilizing ternary complex
formation. This is an example of how nature can eﬀec-
tively produce diﬀerent catalytic eﬀects by enabling
enzymes to perform distinct chemical reactions even
in the presence of essentially the same functions at the
active site.
THE TOPRIM SEQUENCE AS THE CATALYTIC
METAL ION(S) ANCHORING SITE IN
TOPOISOMERASES IA AND II
Starting from the above mentioned mechanistic similari-
ties in phosphodiester processing enzymes and from bio-
chemical evidence, iterative proﬁle searches were extended
to a number of enzymes including DnaG-type primases,
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Figure 1. Roles of Mg
2+ in topoisomerase-mediated transphosphoryla-
tion catalysis: (A) activation of attacking nucleophile (outer sphere); (B)
stabilization of tyrosinate; (C) stabilization of transition state; and (D)
stabilization of leaving group.
Table 1. Principal biochemical features of the DNA topoisomerases
Type Subfamily Name Organism(s) ATP required Mg required Linkage to tyrosine Mechanism Toprim
I IA Topo I Eubacteria, archaea, plants / + 50 Strand passage Yes
Topo III Eubacteria, archaea, eukaryotes / + 50 Strand passage Yes
Reverse gyrase Eubacteria, archaea + + 50 Strand passage Yes
IB Topo I Eukaryotes, viruses, plants / / 30 Controlled rotation No
IC Topo V Archaea / / 30 Controlled rotation No
II IIA Topo II Eukaryotes + + 50 Strand passage Yes
Gyrase Eubacteria, archaea, plants + + 50 Strand passage Yes
Topo IV Eubacteria + + 50 Strand passage Yes
IIB Topo VI Archaea, plants + + 50 Strand passage Yes
704 Nucleic Acids Research, 2009, Vol. 37,No. 3small primase-like proteins from bacteria and archaea,
type IA and type II topoisomerases, bacterial and archaeal
nucleases of the OLD family and bacterial DNA repair
proteins of the RecR/M family (29). These studies
revealed a conserved domain spanning about 100 residues,
called Toprim, characterized by the invariant presence of
a glutamate residue and an aspartate-x-aspartate (DxD)
motif. The glutamate is located in a sharp turn connecting
a b-strand to an a-helix. A structurally similar arrange-
ment is observed at the level of the DxD element. As a
consequence of Toprim folding, the three acidic residues
get close in space and become available for concerted
interactions, as conﬁrmed by the X-ray crystallographic
studies of several Toprim-containing enzymes, including
the Saccharomyces cerevisiae topoisomerase II (Figure 2)
(30). Given its chemical nature and the requirement for
Mg
2+, the triad motif has been proposed to represent the
metal ion(s) binding element in the catalytic core.
The fact that both ATP-dependent and -independent
topoisomerases, previously considered to be very diverse,
share a common catalytic domain with a conserved gluta-
mate plus DxD motif indicates that they basically share a
uniﬁed reaction mechanism, with the single exception
of topoisomerase IB (31), which was already shown
to stand alone in the topoisomerase family (Table 1).
Moreover, a distinct structural, functional and evolu-
tionary relationship between topoisomerase IB and site--
speciﬁc recombinases has been demonstrated (32),
conﬁrming that this family is indeed unrelated to the
Toprim domain-containing topoisomerases.
The details of Toprim interactions with divalent ions
and the mechanistic and catalytic consequences of metal
ion binding have been the object of several investigations
both on topoisomerase IA and II families. The positions
of the key catalytic residues for several members of the
above families are schematically presented in Table 2.
MAGNESIUM IN TYPE IA TOPOISOMERASES
Early studies on the IA subfamily of type I DNA topo-
isomerases conﬁrmed the importance of magnesium as a
cofactor in enzyme activity. In fact, the classical Toprim
B
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Figure 2. Structural organization of the Toprim domain in the
topoisomerase family. (A) Schematic representation of the location
of the conserved aspartate and glutamate residues with blue arrows
representing tracts of b-barrel secondary structures and red cylinders
helical arrangements. (B) Three-dimensional structures of the DxDxD
and E catalytic Toprim residues coordinated to a Mg
2+ ion in
S. cerevisiae topoisomerase II bound to DNA (obtained from the
PDB ID 2RGR).
Table 2. Sequence alignment of the catalytically relevant residues in Toprim-containing topoisomerases
a
Type IA Glu Asp Asp Glu Tyr Chain length
Topo I (E. coli) 9 111 113 115 319 865
Topo I (Y. pestis) 9 117 119 121 325 871
Topo III (E. coli) 7 103 105 107 328 653
Reverse gyrase (A. fulgidus) 512 631 633 635 809 1054
Type IIA Glu Asp Asp Asp Tyr Chain length
TopoII (Human a) 454 541 543 545 805 1531
TopoII (Human b) 477 557 559 561 826 1626
TopoII (S. cerevisiae) 450 527 529 531 782 1428
Gyrase (E. coli) GyrB 424 498 500 502 GyrA 122 804+875
TopoIV (E. coli) ParE 418 490 492 494 ParC 120 630+752
Type IIB Tyr Glu Asp Asp Chain length
TopoVI (Sulfolobus shibatae) Subunit A 106 209 261 263 389
aGyrase, topoisomerase IVand topoisomerase VI consist of two subunits.
Nucleic AcidsResearch, 2009, Vol.37,No. 3 705sequence is reinforced by the generally found DxDxE
motif (33,34), which contains a further acidic glutamate
to grant more eﬃcient metal ion binding, possibly allow-
ing greater structural adaptability of the Toprim complex
and more eﬃcient transphosphorylation catalysis (35).
A positive relationship was found between the relax-
ation activity of the Escherichia coli enzyme and the con-
centration of Mg
2+ from 0mM to 10mM, with near
saturation of the metal requirement at 2.5mM (36).
Subsequently, the enzyme was found to be able to bind
stoichiometric amounts of Mg
2+, producing a stable
metal–enzyme complex. This promoted the relaxation of
negatively supercoiled DNA and produced DNA cleavage
without further addition of Mg
2+, inferring that Mg
2+
ions could bind to speciﬁc site(s) on the enzyme even in
the absence of the DNA substrate. This suggested that the
contact of the metal ion to one or more DNA phosphates
might occur through replacement of at least one of the
original protein–Mg
2+ coordination bonds, yet still allow-
ing catalysis without the need for extensive ion-mediated
protein–DNA interactions. Among protein residues,
Glu-9, Asp-111, Asp-113 and Glu-115 appeared to be
the likely candidates involved in Mg
2+ binding (34).
Surprisingly, site-directed mutagenesis producing alanine
substitution in several strictly conserved key residues
showed that, in the Toprim domain, only substitution at
Glu-9 was able to aﬀect the transesteriﬁcation process
(37). The conclusion followed that Mg
2+ is mainly
required for conformational changes in the enzyme–
DNA complexes rather than for DNA strand cleavage
and rejoining and that the amount of Mg
2+ required for
removal of negative supercoils is much higher than that
for DNA rejoining. Notably, Asp-113 was not selected for
mutagenesis in this case, which might imply that metal ion
binding is compatible with just one of the acidic groups in
the DxD sequence.
This issue was considered by investigating Asp-111 and
Asp-113 double mutants, which were found to lose over
90% of their activity in the relaxation assay in the pres-
ence of Mg
2+. In addition, metal ion concentrations well
above those used for the wild-type enzyme (and there-
fore inhibitory) were needed by double mutants for max-
imal relaxation activity. Inductively coupled plasma
analysis showed the loss of 1–2 Mg
2+ ions per enzyme
molecule due to mutation, consistent with a 1:1 or 2:1
metal ion:topoisomerase stoichiometry in the wild-type
enzyme. These results demonstrate a functional role for
the acidic residues in the binding of Mg
2+ to induce the
conformational change required for the relaxation of
supercoiled DNA (33).
Another interesting mutant in Toprim domain was
characterized by Yersinia pestis topoisomerase I. Indeed,
from sequence analysis and site-directed mutagenesis, it
was shown that changing a single strictly conserved
Gly residue to Ser (G116S) in the Y. pestis topoisomerase
I (or in the corresponding position of the E. coli enzyme)
can result in a mutant enzyme that entails SOS-inducing
and cell-killing properties through a stabilization of the
covalent complex with DNA (38).
Overexpression of this mutant topoisomerase I resulted
in bacterial cell death. The puriﬁed enzyme lost relaxation
activity, yet it still formed a covalent complex and retained
the ability to cleave DNA. These results suggest that a
mutation close to the DxD diad could interfere with
Mg
2+ binding and so impair the enzyme re-ligation step.
Perhaps, this might happen because the Ser OH displaces
the deoxyribose hydroxyl from its correct location in the
metal ion coordination sphere. Hence, perturbation of the
active site region of bacterial topoisomerase I can result in
stabilization of the cleavage complex, thereby producing
bacterial cell death in a similar way to eukaryotic topo-
isomerase poisons.
Several other mutants at the Toprim glycine of Y. pestis
topoisomerase I were examined (39). While the Gly to Ala
substitution allowed both DNA cleavage and re-ligation,
the 17 amino acid substitutions subsequently tested com-
pletely suppressed DNA cleavage activity. This is appar-
ently a consequence of the steric hindrance generated
when replacing the small and ﬂexible, strictly conserved,
Gly side chain with larger groups. On the other hand,
activity retained by the Ser mutant could be remarkably
increased by introducing a second mutation on the Met
residue adjacent to the active site tyrosine. Induction of
the double mutant topoisomerase resulted in up to 40-fold
increase in cell killing rate when compared to the single
Gly116Ser mutant. Fluorescence studies monitoring tryp-
tophan emission upon addition of Mg
2+ indicated very
similar Mg
2+-binding aﬃnity of the double mutant with
reference to the single mutant. Accordingly, the relaxation
activity of the double mutant did not increase by increas-
ing Mg
2+ concentration in the relaxation reaction buﬀer.
Hence, reduced re-ligation has nothing to do with
impaired metal ion binding, but with structural changes
in the Toprim sequence.
Very recently, another signiﬁcant Toprim substitution
was investigated (40). Introduction of a new positive
charge into the active site was achieved by producing a
Met to Arg substitution next to the nucleophilic tyrosine.
The mutant topoisomerase I showed a shift to basic pH
values for optimal activity and a decreased Mg
2+ binding
aﬃnity. As might be expected, the electrostatic potential
map of the minimized mutant structure showed a signiﬁ-
cant increase in positive electrostatic potential with con-
comitant decrease in electron density at the level of the
acidic triad. These changes in electrostatic potential in the
active site region due to the Met to Arg substitution are
clearly expected to aﬀect the Mg
2+ binding aﬃnity of
the mutant topoisomerase and inhibit DNA re-ligation.
MAGNESIUM IN TYPE II TOPOISOMERASES
Given the close similarity in the catalytic metal ion bind-
ing domain and the Mg
2+ requirement for activity, the
results obtained with type II topoisomerases correlate
well with those previously discussed for type IA enzymes.
The role of divalent metal ions in eukaryotic topoisom-
erase II-mediated reactions was recognized long ago
(41–43).
Magnesium ions were found to promote enzyme–
substrate interactions in at least two ways: (i) direct invol-
vement in enzyme-mediated DNA cleavage reactions and
706 Nucleic Acids Research, 2009, Vol. 37,No. 3(ii) participation in ATPase reactions and functions by
providing the enzyme with a magnesium–ATP substrate.
In contrast, the divalent cation did not aﬀect the quater-
nary structure of the enzyme as shown by sedimentation
velocity experiments in the presence/absence of Mg
2+.I n
addition, it did not aﬀect the site-speciﬁcity of topo-
isomerase II binding to DNA, nor did it interfere with
the enzyme’s ability to discern the topological state of
its nucleic acid substrate. It is useful to note that in the
topoisomerase II family the DxD motif is generally
extended to a DxDxD conserved pattern that oﬀers an
additional carboxylic site to generate a structural and
electronic network for coordination and correct position-
ing of the catalytically relevant magnesium ion(s) once
more in a similar way to the IA family characterized by
the DxDxE motif (29,33).
Mutagenesis studies were performed on the human
topoisomerase II b-isoform in the breakage-reunion
domain containing the highly conserved acidic residues.
In particular, a Glu 477 to Gln mutation was found to
greatly impair both DNA decatenation and relaxation
activity. In addition, it reduced the level of cleavage by
more than two orders of magnitude and magnesium
concentration had to be increased for DNA damage detec-
tion. Strand passage also required higher concentrations
of the metal ion in the mutant with reference to the wild-
type enzyme. This was considered as evidence for a
reduced binding aﬃnity of the topoisomerase to the mag-
nesium ion(s) required for DNA cleavage. The above
ﬁndings also highlight the participation of Glu477 in
metal ion coordination during catalysis (44).
The prokaryotic topoisomerase, gyrase, was also exam-
ined in terms of Mg
2+ eﬀects on the enzymatic functions
of DNA cleavage and re-ligation using site-directed muta-
genesis. The Toprim acidic residues Glu424, Asp498,
Asp500 and Asp502, located in the B-subunit, were
mutated separately to alanine. Besides the above muta-
tions, the glutamate 424 and the aspartate 498 residues
were mutated to glutamine and asparagine, respectively
(45). As expected, these residues were found to play an
important role for the cleavage–re-ligation reaction. In
fact, the activity of all mutants was reduced signiﬁcantly
to between 4% and 20% of the wild-type enzyme and,
remarkably, it showed a dependence upon metal ion
concentration which was modiﬁed in comparison to the
wt activity proﬁle. A notable decrease in DNA cleavage
was also detected for the mutant enzymes when compared
to their wt counterpart in the presence of gyrase poisons
(quinolones) or calcium ions which are known to produce
eﬀects similar to the drugs. Also, a substantial increase in
Mg
2+ concentration was required to detect cleavage in the
absence of poisons. To note, mutations were able to alter
metal ion speciﬁcity and, using magnesium and calcium
ions, the actual enzyme activity measured in the presence
of both metals was greater than the sum of the individual
metal ion concentration dependencies. The conclusion
follows that at least two metal ions participate in the
gyrase-mediated DNA cleavage–rejoining processes.
A model applicable to type IA and type II topoisom-
erases (and to other enzymes containing the Toprim fold)
has been proposed for this process, according to which
polarization of the tyrosine residue and stabilization of
the 30-hydroxyl group are mediated by Mg
2+. In the
two-metal ion model, one Mg
2+ stabilizes the pentacova-
lent phosphate transition state as well as the 30- oxyanion
group to make it a better leaving group. The other metal
ion stabilizes the negatively charged transition state, and
polarizes the attacking tyrosine residue, so as to render it
more susceptible to deprotonation. This corresponds to
the modes of metal ion participation in the catalytic
events depicted in Figure 1. Both ions are coordinated
to the Toprim acidic residues, thus forming an organized
structural network close to the active tyrosine and appro-
priate for processing the nucleic acid phosphodiester link-
age. The DNA-rejoining reaction is considered to proceed
similarly, with the ﬁrst ion activating the 30-hydroxyl
group and the second facilitating the leaving of the tyro-
sine residue in a multi-centred relay mechanism.
For a deeper insight into the metal ion eﬀects on DNA
gyrase activity, the enzyme B subunit, its 43kDa and
47kDa domains, and two mutants in the Toprim
domain (Asp498Ala and Asp500Cys) were examined in a
biophysical study (circular dichroism and protein melting
experiments) (46). It turned out that Mg
2+ ions did not
modify the conformational properties of the enzyme sub-
unit at room temperature, but were able to produce selec-
tive and diﬀerential eﬀects on protein stability. In
particular, the protein’s melting proﬁles were generally
shifted towards lower temperature, showing that divalent
cations produced destabilizing eﬀects on gyrase B folding.
These eﬀects were essentially located in the 47kDa
C-terminal domain, containing the Toprim sequence.
Melting studies on the gyrase B mutants showed that the
Asp498 mutant had little eﬀect on the binding of mag-
nesium, whereas the Asp500 mutation impaired Mg
2+
aﬃnity to a large extent, suggesting eﬀective contacts
between this residue and the metal ion in the wild-type
enzyme. Hence, the Toprim domain is conﬁrmed as the
principal selective site for metal ion complexation. These
results point to a double role played by divalent metal ions
in the catalytic steps in which the DNA gyrase B subunit
participates: a direct involvement of cations bound to the
Toprim domain in the DNA cutting–rejoining process and
a striking increase in protein ﬂexibility produced by ion
binding. The latter event facilitates the huge conforma-
tional changes essential for the catalytic cycle to be per-
formed and possibly allows the Toprim domain to be
properly positioned relative to the Tyr122 residue in the
active form of the enzyme. On the other hand, the GyrA
subunit was much less prone to structural modiﬁcations
upon addition of divalent ions. However, it is worth
recalling that a Glu84Pro mutation in ParC, the GyrA
equivalent in Topoisomerase IV, inhibits the formation
of covalent topoisomerase IV–DNA complexes when
Mg
2+, but not Ca
2+, is used as a cofactor (47). This
points to the participation of residue 84 in interactions
with magnesium, the mutation possibly aﬀecting the coor-
dination of the divalent cation in the topoisomerase
IV–DNA complex. However, no Mg
2+ was found in the
crystal structures of GyrA or corresponding topoisom-
erase II sequences. On the other hand, the presence of
the target DNA might be required to allow Glu84 (or its
Nucleic AcidsResearch, 2009, Vol.37,No. 3 707equivalent in GyrA) to participate in metal ion-mediated
interactions within the cleavable complex. This general
issue was raised during an investigation on the eﬀects of
the presence of the nucleic acid in complex with reconsti-
tuted DNA gyrase (48).
The addition of divalent metal to the reconstituted
enzyme required higher metal ion concentrations to pro-
duce structural changes comparable to those in GyrB,
which conﬁrms a supposed scaﬀold role of GyrA in reg-
ulating the overall enzyme structure. Chiroptical studies
showed two distinct conformational changes in the pres-
ence of Mn
2+ (a metal ion conferring full activity to the
enzyme), which points to the presence of at least two
discrete metal ion binding sites, each aﬀecting protein
folding to a diﬀerent extent. Combining this and the
previous information obtained using GyrB suggests that
the two distinct conformationally relevant binding events
occur in the Toprim region. The ﬁrst structural transition
is associated to a 1:1 stoichiometry, while the subsequent
conformational change probably corresponds to the
second coordination event. Most interestingly, however,
the catalytically signiﬁcant coordination arrangement
can be observed only in the presence of the DNA chain,
which points to an active role played by the nucleic acid
within the gyrase catalytic complex. Apparently, the poly-
nucleotide substrate represents a crucial component in
properly recruiting the metal ion cofactors necessary to
correctly perform the cleavage–rejoining cycle of the
type II enzyme. Moreover, the data obtained after recon-
stitution of Gyrase with two GyrB mutants underline a
diﬀerential role played by residues at position 498 and
500. It is proposed that residue Asp498 participates in
the coordination sphere of the second metal ion, whereas
residue Asp500 is mainly involved in the ﬁrst complexa-
tion event.
The crystal structure of the DNA binding and cleavage
core of S. cerevisiae type IIA topoisomerase bound to
prospective gate-segment DNA has been recently reported
and the structural organization of the catalytic site dis-
sected at atomic resolution (30). Interestingly, a magne-
sium ion is modelled at the level of the Toprim Glu450,
Asp527 and Asp 529 residues, essentially conﬁrming the
coordination scheme thus far discussed. However, only
one metal ion is present. This would at ﬁrst glance con-
tradict the two-metal ion mechanism discussed above and
supported by convincing evidence in both type IA and
type II topoisomerases. Conceivably, a second metal ion
could be accommodated in the catalytic site of the yeast
topoisomerase, but is probably missing in the crystal
structure because of the absence of a scissile phosphate
in the cleavage position of the oligonucleotide substrate.
Indeed, as suggested by recent work (48), the second metal
ion needs the presence of the (scissile) DNA phosphate to
be appropriately coordinated in the catalytic pocket. The
proposed mechanism appears to hold also for the human
type IIa topoisomerase as reported in a very recent inves-
tigation using a series of divalent metal ions with varying
thiophilicities in conjunction with DNA cleavage sub-
strates in which the 30-bridging oxygen of the scissile
bond is replaced by a sulphur atom (49).
Critical interactions between the divalent cations and
the latter bond, important for the DNA cleavage event
mediated by the enzyme, were determined using the thi-
olated substrates. Kinetic measurements carried out on
the above substrates using diﬀerent cationic species
alone or in combination strongly suggest that two divalent
metal ions are required for catalysis. The emerging model
closely resembles that discussed above for DNA gyrase.
Amino acids likely to interact with the metal ions in the
active site of topoisomerase IIa are Asp541, Asp543,
Asp545 (DxDxD motif) and Glu461. Conceivably, one
of the divalent cations binds the 30-phosphate oxygen to
facilitate the cleavage event, while the other is postulated
to stabilize the DNA transition state and/or help depro-
tonate the active site tyrosine (Figure 1).
CONCLUDING REMARKS
The results thus far discussed show unambiguously that
divalent metal ions, particularly magnesium, play a major,
indispensable role in promoting the DNA cleavage–
rejoining activity of topoisomerases through both par-
ticipation in the catalytic events and assistance in the
appropriate structural changes to assemble/disassemble
the active site. Catalytic Mg
2+ species are consistently
bound to a speciﬁc region in the active site.
Interestingly, in both IA and II enzymes the metal ions
are tightly anchored to the protein backbone through four
conserved, closely located, carboxyl side chain residues
(Asp, Glu), more abundant than other Toprim-containing
enzymes. Considering that topoisomerases perform two
sequential phosphoryl transfer reactions with large con-
formational changes in-between, this might be related to
the need to keep the 30-OH end produced by the cleavage
reaction ﬁrmly connected to the acidic sequence, hence in
place to perform re-ligation (34). Losing contact with the
enzyme would surely render the latter process less eﬃcient.
It is worth considering a key diﬀerence in the relaxation
step between type IA and IB topoisomerases. In fact, while
type IA enzymes perform a strand passage mechanism
changing the linking number one by one, type IB enzymes
conduct multiple linking number changes by a free rota-
tion mechanism. Apparently, participation of the metal
ion grants stricter control in the resealing of the cut
DNA strand each time strand passage occurs. This is rea-
sonable considering the multiple coordination ability of
Mg
2+ when compared to the proton relay catalytic mech-
anism characteristic of the IB topoisomerases (50).
Hence, it appears that a very organized ionic network is
formed close to the transphosphorylation centre, connect-
ing the anionic centres in Toprim and the anionic centre in
the nucleic acid through divalent (magnesium) ions.
Remarkably, this is true also for DNA gyrase for which
Toprim is located in one subunit and the active tyrosine in
the other.
A two-ion model is generally suggested for Toprim
containing type IA and Type II enzymes (33,45,48,49).
This probably facilitates a relay-like mechanism, in
which the two metals are possibly not ﬁxed in space, but
may undergo coordination rearrangements to cope with
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support of the cleavage and, subsequently, the rejoining
process. Considering that the second Mg
2+ is probably
recruited by the nucleic acid binding to the enzyme, only
one ion could be constitutively associated to the enzyme.
This tightly bound magnesium would explain the discre-
pancies deriving from reports questioning the absolute
requirement of the metal ion in the phosphodiester cleav-
age process. In addition to increasing relaxation activity
in topoisomerase IA, increasing Mg
2+ concentration also
produces changes in the DNA cleavage patterns (51). This
behaviour is not simply explicable in terms of the two-ion
mechanism, but might be related to progressive changes
in plasmid conformation (winding) caused by the metal
ion (52), which is known to bind eﬃciently to the nucleic
acid producing tightly bound ion pairs (53). Protein
conformational changes at metal ion concentrations well
above physiological could additionally contribute.
In connection with this, another invariant ﬁnding in
ion-mediated topoisomerase function is the bell-shaped
dependence of the cleavage process eﬃciency upon diva-
lent ion concentration. This is probably the result of the
competition between diﬀerent binding events involving
the three partners (topoisomerase, DNA and ion). As
mentioned above, both the protein and the nucleic acid
eﬃciently bind divalent metals. We can therefore envisage
the formation of binary topoisomerase–metal and
DNA–metal complexes, along with the productive ternary
complex. Upon increasing metal ion concentration, ter-
nary complex formation continues to increase up to the
point at which the splitting of this complex into two
binary systems occurs simply according to mass law. In
fact, the process
topoisomerase   DNA   metal þ metal  !    
topoisomerase   metal þ DNA   metal
is obviously shifted to the right by increasing the concen-
tration of the metal ion above a given threshold. This is
determined, besides the concentrations of the interacting
species, by the relative aﬃnities of the metal for ternary
versus binary complexes and is further conﬁrmed by the
fact that diﬀerent metals exhibit diﬀerent concentration
windows for optimal cleavage. It is, however, worth men-
tioning that active site-mutated type IA topoisomerases
still exhibit single-stranded DNA (ssDNA) binding ability
which is not aﬀected by Mg
2+. Since the metal ion is likely
to bind a double-stranded nucleic acid more tightly than a
ssDNA due to the higher charge density exhibited by the
former (54), the metal ion concentration required to split
the ternary complex in topoisomerases IA could be signiﬁ-
cantly higher in comparison to that required in topo-
isomerases II. Moreover, type I and type II enzymes
could be further conformationally aﬀected to diﬀerent
extents by increasing ionic strength, thus exhibiting distinct
proﬁles of inactivation as a function of added metal ion.
As pointed out above, a great deal of information on
the molecular mechanisms of the action of topoisomerases
has been gained not only by site-directed mutagenesis, but
also by changing the nature of the catalytic metal ion.
In particular, both Ca
2+ and Mn
2+ were able to modulate
enzyme activity and allowed the ﬁne details of the mode of
action to be understood (48,49). Like magnesium, calcium
is redox-inert and prefers hard donors such as oxygen. It is
characterized by a larger ionic radius (1A ˚ ), hence a lower
charge density and a higher ﬂexibility to accommodate
ligand groups in its coordination sphere (55). These prop-
erties render it less eﬀective in transesteriﬁcation catalysis,
in particular in the re-ligation process.
The functional role of Mn
2+ rests on its properties as a
Lewis acid and an electrostatic stabilizer. It represents a
good substitute for Mg
2+ due to the similar length of its
radius (0.83A ˚ ) and its borderline hard–soft character (56).
The latter feature can be helpful to detect speciﬁc contacts
between the enzyme or the nucleic acid species since sub-
stitution of oxygen atoms with sulphur (or introduction of
sulphur-containing groups) would substantially enhance
manganese binding. These important details of the two-
metal ion model would not be available without metal ion
replacement studies.
Not only do divalent metal ions participate in topoi-
somerase catalysis, but they might also play a role in
enzyme poisoning. In fact, a number of topoisomerase
II-directed drugs (no compound aimed at topoisomerase
IA has been thus far described), including quinolones (57),
quinobenzoxazines (58), bisbenzoxazoles, (59) anthraqui-
nones (60), anthracyclines (61) and epipodophyllotoxins
(62) have been reported to participate in metal ion binding
(in many instances Mg
2+) when forming stable complexes
with biological macromolecules. It is conceivable that
metal ion binding ability can be exploited when the drug
is sitting in the cleavage complex and inhibits the DNA
resealing process. It would not be surprising that metal-
chelating groups of the drug molecules participate in the
Mg
2+ coordination sphere, displacing the 30-hydroxyl
ligand from proper positioning and also reducing favour-
able electronic eﬀects thus enhancing the activation energy
barrier in the DNA resealing step. This would represent a
further until now overlooked topoisomerase poisoning
mechanism. Further investigations are warranted to dis-
sect this point and to assess its potential use in rational
drug design and development. In this connection, topoi-
somerase IA might be exploited as a novel target for anti-
bacterial action by developing small molecules able to
speciﬁcally interfere with the Mg
2+-dependent re-ligation
process. This would be beneﬁcial for successful treatment
of bacterial infections resistant to current topoisomerase
II inhibitors (63).
To conﬁrm that such a strategy might be rewarding, a
similar approach has proven fruitful in the inhibition of
divalent ion-dependent strand transfer by HIV-1 inte-
grase. In fact, raltegravir, which acts by chelating the
ion cofactor(s) located at the active site of this enzyme,
has recently been approved by the U.S. Food and Drug
Administration for clinical treatment of AIDS (64).
Therefore, a detailed knowledge of metal ion participation
in topoisomerase-related processes might not only hold
mechanistic relevance, but also open new avenues for tar-
geted therapeutic intervention.
In conclusion, type IA and type II topoisomerases per-
form their catalytic job with a mechanism resembling sev-
eral other types of DNA-processing and RNA-processing
Nucleic AcidsResearch, 2009, Vol.37,No. 3 709enzymes including DNA-and RNA-polymerases, restric-
tion endonucleases, transposases, primases and integrases
(16). Interestingly, the apparently divergent functions of
these enzymes exhibit a substantially conserved reaction
pattern, which can yield a uniﬁed view of the making and
cleaving phosphodiester bond reactions in nucleic acids.
In fact, divalent ions, almost invariably magnesium in the
two-ion mechanism, are required to allow and modulate
polarization of the reacting phosphate group to facilitate
some of the fundamental biochemical processes needed
for cell life and proliferation. These ions are ﬁrmly held
in the catalytic pocket by carboxylate groups belonging to
invariant aspartic/glutamic acid residues and are ready to
coordinate the DNA/RNA substrate to produce an acti-
vated complex. Interestingly, topoisomerases perform
both the cleaving and rejoining step alternatively pro-
duced by the other enzymes, in this connection represent-
ing the bridge between the phosphodiester bond makers
and disrupters and conﬁrming that common active site
chemical and structural features have evolved to govern
apparently opposite biochemical processes for nucleic
acids manipulation.
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